Search research articles
Contact Us
Filters
Showing results (81-90 of 132) with videos related to
Page
of 14
Sort By:
Journal of Thrombosis and Haemostasis : JTH
|
August 3, 2017
Minimal dataset for post-registration surveillance of new drugs in hemophilia: communication from the SSC of the ISTH
F Peyvandi, M Makris, P Collins, et al.
British Journal of Haematology
|
January 1, 1995
Rapid genotype analysis in type 2B von Willebrand's disease using a universal heteroduplex generator
N Wood, G R Standen, E W Murray, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
September 22, 2012
Bleeding disorders, menorrhagia and iron deficiency: impacts on health-related quality of life
C Rae, W Furlong, J Horsman, et al.
Environmental Toxicology and Chemistry
|
April 24, 2007
Evaluation of the reproductive effects of tamoxifen citrate in partial and full life-cycle studies using fathead minnows (Pimephales promelas)
Tim D Williams, John E Caunter, Adam D Lillicrap, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 15, 2010
ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders
F Rodeghiero, A Tosetto, T Abshire, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
January 20, 2009
Non-neutralizing anti-FVIII antibodies: different binding specificity to different recombinant FVIII concentrates
A M Vincent, D Lillicrap, A Boulanger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
July 14, 2005
Can activated recombinant factor VII be used to postpone the exposure of infants to factor VIII until after 2 years of age?
G E Rivard, D Lillicrap, M C Poon, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 9, 2007
Different clinical phenotype in triplets with haemophilia A
C Barnes, V Blanchette, D Lillicrap, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 2, 2008
Reduction of the immune response to factor VIII mediated through tolerogenic factor VIII presentation by immature dendritic cells
M Qadura, M Othman, B Waters, et al.
British Journal of Haematology
|
December 1, 1991
Recurring mutations at CpG dinucleotides in the region of the von Willebrand factor gene encoding the glycoprotein Ib binding domain, in patients with type IIB von Willebrand's disease
D Lillicrap, E W Murray, K Benford, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 132) with videos related to
Sort By:
Page
of 14
Journal of Thrombosis and Haemostasis : JTH
|
August 3, 2017
Minimal dataset for post-registration surveillance of new drugs in hemophilia: communication from the SSC of the ISTH
F Peyvandi, M Makris, P Collins, et al.
British Journal of Haematology
|
January 1, 1995
Rapid genotype analysis in type 2B von Willebrand's disease using a universal heteroduplex generator
N Wood, G R Standen, E W Murray, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
September 22, 2012
Bleeding disorders, menorrhagia and iron deficiency: impacts on health-related quality of life
C Rae, W Furlong, J Horsman, et al.
Environmental Toxicology and Chemistry
|
April 24, 2007
Evaluation of the reproductive effects of tamoxifen citrate in partial and full life-cycle studies using fathead minnows (Pimephales promelas)
Tim D Williams, John E Caunter, Adam D Lillicrap, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 15, 2010
ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders
F Rodeghiero, A Tosetto, T Abshire, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
January 20, 2009
Non-neutralizing anti-FVIII antibodies: different binding specificity to different recombinant FVIII concentrates
A M Vincent, D Lillicrap, A Boulanger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
July 14, 2005
Can activated recombinant factor VII be used to postpone the exposure of infants to factor VIII until after 2 years of age?
G E Rivard, D Lillicrap, M C Poon, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 9, 2007
Different clinical phenotype in triplets with haemophilia A
C Barnes, V Blanchette, D Lillicrap, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 2, 2008
Reduction of the immune response to factor VIII mediated through tolerogenic factor VIII presentation by immature dendritic cells
M Qadura, M Othman, B Waters, et al.
British Journal of Haematology
|
December 1, 1991
Recurring mutations at CpG dinucleotides in the region of the von Willebrand factor gene encoding the glycoprotein Ib binding domain, in patients with type IIB von Willebrand's disease
D Lillicrap, E W Murray, K Benford, et al.
Page
of 14